perfluoroethane

05/01/2012 - "To evaluate the role of postoperative prone posturing for a single night in the outcome of trans pars plana vitrectomy (TPPV) with internal limiting membrane (ILM) peel and 20% perfluoroethane (C2F6) internal tamponade for idiopathic macular hole. "
12/01/1992 - "Seventeen eyes with retinal detachments with single retinal breaks or groups of breaks no greater than 1 clock hour in extent were prospectively treated with perfluoroethane gas injection and retinocryopexy and followed up for a minimum of 6 months. "
02/01/2012 - "To compare the outcomes of non-posturing macular-hole surgery using sulfur hexafluoride (SF(6)) gas versus perfluoroethane (C(2)F(6)) for idiopathic macular hole repair. "
02/01/2012 - "Outcomes of sulfur hexafluoride (SF6) versus perfluoroethane (C2F6) gas tamponade for non-posturing macular-hole surgery."
04/01/2016 - "In this prospective randomized study, 21 consecutive patients who were unsuccessfully operated on for large idiopathic full-thickness macular hole were randomly assigned to undergo a second vitrectomy with 20% perfluoroethane gas (C2F6, Group A) or with Densiron 68 tamponade (Group B). "

10/01/2006 - "Surgery comprised pars plana vitrectomy, peeling of any epiretinal membrane, 17% C2F6 (hexafluoroethane) gas filling and 10 days of positioning. "
09/01/2001 - "Surgery consisted of a standard three-port vitrectomy, induction of a posterior hyaloid detachment, removal of epiretinal membranes including the ILM, fluid-air exchange and intraocular gas tamponade (15% hexafluoroethane (C2F6) gas mixture) followed by head-down positioning for at least five days. "
04/01/1996 - "The procedure consisted of pars plana vitrectomy with removal of posterior cortical vitreous, stripping of associated epimacular membranes, 15% perfluoroethane-air tamponade, and instillation of autologous platelet concentrate onto the posterior pole. "

07/01/1998 - "To evaluate perfluoroethane in the treatment of retinal detachment. "
07/01/1998 - "[The application of perfluoroethane made in China for treatment of retinal detachment]."
12/01/1992 - "Pneumatic retinopexy perfluoroethane (C2F6) in the treatment of rhegmatogenous retinal detachment."
12/01/1992 - "Seventeen eyes with retinal detachments with single retinal breaks or groups of breaks no greater than 1 clock hour in extent were prospectively treated with perfluoroethane gas injection and retinocryopexy and followed up for a minimum of 6 months. "
07/01/1998 - "Various percentages of perfluoroethane were used and combined with routine scleral buckling and/or vitrectomy to treat 100 cases of retinal detachment. "

07/01/2014 - "To evaluate the efficacy and safety of pneumodescemetopexy with intracameral perfluoroethane (C2F6) gas for the treatment of acute hydrops secondary to keratoconus. "
07/01/2014 - "Pneumodescemetopexy with perfluoroethane (C2F6) for the treatment of acute hydrops secondary to keratoconus."
12/01/2009 - "Management of bilateral acute hydrops secondary to keratoglobus with perfluoroethane (C2F6) pneumodescemetopexy."

07/01/2014 - "To evaluate the efficacy and safety of pneumodescemetopexy with intracameral perfluoroethane (C2F6) gas for the treatment of acute hydrops secondary to keratoconus. "
07/01/2014 - "Pneumodescemetopexy with perfluoroethane (C2F6) for the treatment of acute hydrops secondary to keratoconus."
12/01/2009 - "Management of bilateral acute hydrops secondary to keratoglobus with perfluoroethane (C2F6) pneumodescemetopexy."